LogicBio Therapeutics (LOGC) Misses Q3 EPS by 4c

November 8, 2024 6:45 AM

LogicBio Therapeutics (NASDAQ: LOGC) reported Q3 EPS of ($0.04).

For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.